We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sankyo Selected Evotec as Assay Development and Screening

News   Apr 28, 2006

 
Sankyo Selected Evotec as Assay Development and Screening
 
 
 

RELATED ARTICLES

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Scientists Develop New Drug Treatment for TB

News

Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals. The team hope the compound –developed after 10 years of painstaking research will be trialed on humans within three to four years.

READ MORE

Novel Drug Designed for Pancreatic Cancer

News

A treatment for highly aggressive and commonly fatal pancreatic cancer is being developed, reports a University of Houston researcher who has designed a new medicine that can inhibit two of the major pathways of the deadly disease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE